HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vindevogel’s Vision Healthcare Secures Avista Backing For US Entry

Executive Summary

New York's Avista Capital Partners has taken a 50% stake in Belgian consumer health player Vision Healthcare, which has its sights set on the US market.

You may also be interested in...



Belgium's Damier Acquires Cosmetics Brand Dr. Organic

Yvan Vindevogel's Damier has snapped up UK-based natural beauty specialist Dr. Organic from The Bountiful Company to expand its investment portfolio.

Vision Healthcare Hires Perrigo Execs And Acquires Spanish VMS Player

Vision Healthcare has hired Perrigo's Geert Cools and Joost Hunfeld as CEO and chief growth officer respectively, while at the same time securing the acquisition of Spanish VMS player N2.

Vision Healthcare Expands E-Commerce Reach In EU With Sensilab

Belgium's Vision Healthcare - led by Yvan Vindevogel - has strengthened its growing European e-commerce platform with the acquisition of Slovenia's Sensilab.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150082

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel